Motoric Cognitive Risk Syndrome (MCR) is a predementia stage where slow gait speed and subjective memory complaints are present. The purpose of this study was to estimate the prevalence of MCR and assess its relationship with sociodemographic factors and chronic conditions. This is a secondary analysis of the SABE Colombia study conducted in 2015. The analytic sample consisted of 17·577 participants. After determining MCR prevalence, logistic regression was performed to examine the correlates of MCR. The prevalence of MCR was 10·71 %. The median age was 71 years and women composed 74·63 % of the MCR group. After adjusting for confounding variables MCR was associated with increasing age (OR 1·69, CI 1·43 - 1·92), no or low education (OR 1·99, CI 1·67- 2·37), MMSE (OR 0·93, CI 0·91 - 0·95) and chronic conditions such as mental disorders (OR 1·36, CI 1·11-1·67), history of myocardial infarction (OR 1·24, CI 1·04 - 1·47), hypertension (OR 1·23, CI 1·08 - 1·40) and diabetes (OR 1.18, CI 1.01 – 1.37). This study found a prevalence of 10·71 % of MCR in Colombian older adults. Additionally, MCR was associated with chronic conditions and sociodemographic factors identified in prior studies. These results increase the awareness of a novel predementia stage whose identification can be performed by clinicians in the outpatient clinic, minimizing the cost of a full neuropsychologic evaluation performed in a memory clinic. Funded by the Administrative Department of Science, Technology and Innovation (Colciencias) and the Ministry of Health and Social Protection of Colombia.

BACKGROUND AND OBJECTIVES: The pipeline embolization device (PED) Flex with Shield technology is a third-generation flow diverter used for intracranial aneurysm treatment designed to decrease thrombogenicity through a phosphorylcholine coating. Herein, we aim to compare the rate of thromboembolic events in PED with Shield technology and PED without it through propensity score matching. METHODS: We conducted a retrospective analysis of aneurysms treated with PED first-generation/PED Flex and PED with Shield between 2013 and 2023 at a single academic institution. Patients were matched through propensity score by controlling for confounding factors including age, smoking history, diabetes, previous subarachnoid hemorrhage, modified Rankin Scale pretreatment, location, aneurysm size, previous treatment, and clopidogrel or aspirin resistance. After matching, we evaluated for periprocedural and postoperative thromboembolic events. Data analysis was performed using Stata 14. RESULTS: A total of 543 patients with 707 aneurysms treated in 605 procedures were included in the analysis. From these, 156 aneurysms were treated with PED with Shield (22.07%) and 551 (77.93%) without Shield technology. Propensity score matching resulted in 84 matched pairs. The rate of thromboembolic events was 3.57% for PED Shield and 10.71% for PED first-generation/PED Flex (P = .07), while retreatment rates were 2.38% for PED Shield and 8.32% for PED Flex (P = .09). Complete occlusion at first (P = .41) and last imaging follow-up (P = .71), in-stent stenosis (P = .95), hemorrhagic complications (P = .31), and functional outcomes (P = .66) were comparable for both groups. CONCLUSION: This is the first study in the literature performing a propensity scored–matched analysis comparing PED with PED with Shield technology. Our study suggests a trend toward lower thromboembolic events for PED Shield, even after controlling for aspirin and clopidogrel resistance, and a trend toward lower aneurysm retreatment rates with PED Shield, without reaching statistical significance.

Background/Objectives: Hemodynamic stressors, including abnormal wall shear stress (low or high) or oscillatory shear index are recognized as contributors to the pathogenesis, growth, and rupture of intracranial aneurysms (IAs). Computational fluid dynamics (CFD) has therefore become an essential tool for their quantitative assessment. This systematic review aimed to identify the most frequently analyzed hemodynamic and morphological parameters in recent CFD studies and summarize the methodological strategies employed. Methods: A systematic review was conducted following the PRISMA guidelines, including original studies published between 2019 and 2024 in PubMed, Scopus, Web of Science, and Embase databases. Eligible studies applied CFD to human saccular aneurysms addressing rupture or growth. Exclusion criteria comprised stent-assisted treatments, idealized or phantom models, and non-human or in vitro analyses. Extracted data included study characteristics, CFD software, meshing and solver approaches, and reported parameters. Results: Thirty-five studies met the eligibility criteria. Commercial software predominated across the segmentation, meshing, and solver stages. The most frequently evaluated wall shear stress metrics were the oscillatory shear index (OSI, 91.43%), time-averaged wall shear stress (TAWSS, 71.43%), low shear area ratio (LSAR, 60.00%), normalized wall shear stress (NWSS, 51.43%), and relative residence time (RRT, 45.71%). Morphological parameters such as the aspect ratio (AR, 74.29%), size ratio (SR, 68.57%), and volume (42.86%), reflecting aneurysm shape and relative size, were the most consistently evaluated and demonstrated strong associations with rupture and growth. Conclusions: A core set of morphological and hemodynamic parameters (AR, SR, TAWSS, OSI, RRT, and LSAR) was consistently identified as potential discriminators for the rupture and growth of intracranial aneurysms. However, substantial methodological heterogeneity and the absence of unified standards hinder reproducibility and clinical translation. Future research must urgently standardize computational frameworks, parameter definitions, and boundary conditions to enhance the consistency, comparability, and clinical applicability of CFD in aneurysm risk assessment.